Download PDF

Other users also viewed these articles

Effectiveness of intravenous tocilizumab in routine clinical practice in a cohort of Costa Rican patients with rheumatoid arthritis Mauricio Cordero-Alfaro; Carlos León-Céspedes; Allan Ramos-Esquivel;
Reumatol Clin. 2021;17:329-34
Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis Alejandro Balsa; Petra Díaz del Campo Fontecha; Lucía Silva Fernández; José Valencia Martín; Virginia Nistal Martínez; Fernando León Vázquez; M. Vanesa Hernández Hernández; Héctor Corominas; Rafael Cáliz Cáliz; José María Aguado García; Gloria Candelas Rodríguez; Nora Ibargoyen Roteta; Arturo Martí Carvajal; M. Nieves Plana Farras; Janet Puñal Riobóo; Hye Sang Park; Yolanda Triñanes Pego; Virginia Villaverde García;
Reumatol Clin. 2023;19:533-48
Safety and effectiveness of bDMARDs during pregnancy in patients with rheumatic diseases: Real-world data from the BIOBADASER registry Cristina Membrive-Jiménez; Carlos Sánchez-Piedra; Olga Martínez-González; Javier García-González; Lorena Expósito-Pérez; Cristina Bohórquez-Heras; Cristina Campos-Fernández; Fernando Sanchez-Alonso; Rafael Cáliz-Cáliz; Isabel Castrejón-Fernández;
Reumatol Clin. 2023;19:500-6